2021 Annual Meeting

Session: Applications of Therapeutic and Enzymatic Protein Engineering

Chair

Lawrence Stern, University of South Florida

Co-Chair

Jamie Spangler, Johns Hopkins University

Presentations

12:30 PM

(462a) Engineered Immunocytokines Improve Delivery of IL-2 to Pro-Inflammatory Cells and Promote Anti-Tumor Activity
Elissa Leonard, Jamie Spangler

12:48 PM

(462b) Directed Evolution of TIMP-Based Protein Scaffolds for Metalloproteinase Inhibition
Maryam Raeeszadeh-Sarmazdeh, Mari Toumaian, Alexander Bolt, Linh Do, Imam Sanousi

01:06 PM

(462c) NAD(H)-Peg Swing Arms Improve Both the Activities and Stabilities of Modularly-Assembled Transhydrogenases Designed with Predictable Selectivities
Nadim Massad, Scott Banta

01:24 PM

(462d) Single c-to-t Substitution Using Engineered apobec3g-ncas9 Base Editors with Minimum Genome- and Transcriptome-Wide Off-Target Effects
Xue Sherry Gao

01:42 PM

(462f) Antibody-Lectin Bispecifics for Targeting Glyco-Immune Checkpoints
Jessica C. Stark, Carolyn Bertozzi, Simon Wisnovsky, Melissa Gray

02:00 PM

(462g) Engineering Ribosomal Natural Products As New Antimicrobials
Aaron Link